Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
12.32
+0.08 (0.65%)
At close: Dec 26, 2025, 4:00 PM EST
12.33
+0.01 (0.08%)
After-hours: Dec 26, 2025, 7:58 PM EST
Viatris Revenue
Viatris had revenue of $3.76B in the quarter ending September 30, 2025, with 0.23% growth. This brings the company's revenue in the last twelve months to $14.12B, down -6.14% year-over-year. In the year 2024, Viatris had annual revenue of $14.74B, down -4.46%.
Revenue (ttm)
$14.12B
Revenue Growth
-6.14%
P/S Ratio
1.03
Revenue / Employee
$441,388
Employees
32,000
Market Cap
14.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.74B | -687.60M | -4.46% |
| Dec 31, 2023 | 15.43B | -835.80M | -5.14% |
| Dec 31, 2022 | 16.26B | -1.62B | -9.08% |
| Dec 31, 2021 | 17.89B | 5.94B | 49.73% |
| Dec 31, 2020 | 11.95B | 445.50M | 3.87% |
| Dec 31, 2019 | 11.50B | 66.60M | 0.58% |
| Dec 31, 2018 | 11.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VTRS News
- 10 days ago - Viatris Provides Pipeline Update on Four Regulatory Milestones - PRNewsWire
- 11 days ago - Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 22 days ago - Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited - PRNewsWire
- 25 days ago - Viatris Inc. (VTRS) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - Viatris Inc. (VTRS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 27 days ago - Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration - GlobeNewsWire
- 4 weeks ago - Viatris to Participate in Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - Viatris Inc. (VTRS) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha